Total submissions: 12
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001082528 | SCV000261783 | benign | Alstrom syndrome | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Center for Pediatric Genomic Medicine, |
RCV000224192 | SCV000281160 | benign | not provided | 2016-01-11 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000444233 | SCV000532109 | benign | not specified | 2016-10-06 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Personalized Diabetes Medicine Program, |
RCV000445400 | SCV000536962 | benign | Monogenic diabetes | 2019-02-08 | criteria provided, single submitter | research | ACMG criteria: BP4 (REVEL score 0.007 + 9 predictors), BA1 (5.1% in African gnomAD), BS2 (36 homozygotes in gnomAD), BP1 (missense in gene with truncating cause disease)= Benign |
Laboratory for Molecular Medicine, |
RCV000444233 | SCV000967032 | benign | not specified | 2016-03-21 | criteria provided, single submitter | clinical testing | p.Thr382Ala in exon 5 of ALMS1: This variant is not expected to have clinical si gnificance because it has been identified in 7.19% (95/1322) of African chromoso mes by the 1000 Genomes Project (Phase 3; dbSNP rs28730849). |
Clinical Genomics, |
RCV001082528 | SCV002605251 | benign | Alstrom syndrome | criteria provided, single submitter | research | Potent mutations in ALMS1 are associated with a rare condition called Alstrom syndrome. It can cause excessive eating, insulin resistance. However, no evidence is found to ascertain the role of rs28730849 in Alstrom syndrome yet. | |
Ambry Genetics | RCV002453744 | SCV002615623 | benign | Cardiovascular phenotype | 2018-12-26 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV000224192 | SCV004701419 | benign | not provided | 2024-07-01 | criteria provided, single submitter | clinical testing | ALMS1: BP4, BS1, BS2 |
Breakthrough Genomics, |
RCV000224192 | SCV005242438 | benign | not provided | criteria provided, single submitter | not provided | ||
Natera, |
RCV001082528 | SCV001458903 | benign | Alstrom syndrome | 2020-09-16 | no assertion criteria provided | clinical testing | |
Genome Diagnostics Laboratory, |
RCV000444233 | SCV002034128 | benign | not specified | no assertion criteria provided | clinical testing | ||
Laboratory of Diagnostic Genome Analysis, |
RCV000224192 | SCV002035702 | likely benign | not provided | no assertion criteria provided | clinical testing |